酮还原酶中立体选择性还原位点的突变及其产物分析

为验证糖多孢红霉菌聚酮合成酶中酮还原酶(Ery KR)的LDD模式序列是否为控制2-甲基环己酮立体选择性还原的位点,构建了分别异源表达聚酮合成酶模块1的酮还原酶(Ery KR1)、模块2的酮还原酶(Ery KR2)、LDD残基替换为PQQ(LDD→PQQ)的EryKR1及PQQ替换为LDD(PQQ→LDD)的Ery KR2的重组大肠杆菌Escherichia coli BL21(p ET28a-eryKR1)、E.coliBL21(pET28a-ery KR2)、E.coli BL21(p ET28a-Tery KR1)和E.coli BL21(p ET28a-Tery KR2)。SDS-PAGE实验证明,经IPTG诱导后4个重组菌中都表达出相应的酮还原酶。粗酶液的比酶活分别为1.49 U/mg、0.37 U/mg、0.94 U/mg和0.31 U/mg。利用气相色谱分别检测4个重组菌还原2-甲基环己酮体系中产物的立体结构,结果显示与野生型Ery KR1的还原产物以顺式-2-甲基环己醇为主不同,LDD→PQQ的突变型Ery KR1催化2-甲基环己酮的还原产物主要为反式-2-甲基环己醇,而PQQ→LDD的突变型Ery KR2的主要还原产物也由野生型Ery KR2的反式-2-甲基环己醇转变成顺式-2-甲基环己醇,证实了LDD模式序列确实为酶中控制2-甲基环己酮立体选择性还原的位点。     

嗜酸氧化亚铁硫杆菌硫氰酸酶的表达、纯化及其性质鉴定

目的:嗜酸氧化亚铁硫杆菌(Acidithiobacillus ferrooxidans)硫氰酸酶是硫代谢中极其重要的酶,其作用主要包括氰化物的解毒,铁-硫蛋白的合成,以及硫胺、硫尿苷或烟碱乙酸胆碱的生物合成,硫氰酸酶的研究对揭示生物冶金机理具有重要的推动作用.方法:以A.ferrooxidans ATCC23270基因组为模板设计引物,通过PCR扩增得到编码硫氰酸酶的基因,目的基因片段与原核表达载体PLM1构建重组体,然后转入大肠杆菌(Eschcrichia coli,E.coli)DH5a感受态中,基因测序正确后,重组质粒再转入E.coli BL21感受态中,加IPTG诱导蛋白表达,用一步亲和层析法纯化出浓度和纯度都较高的硫氰酸酶.结果:SDS-PAGE分析证实蛋白分子量为21kD,紫外可见光分析,确定硫氰酸酶中含有铁硫簇,酶活测定发现重组硫氰酸酶在体外不具有酶活性,可能与酶反应条件及信号肽的切断有关.结论:体外成功克隆.表达,纯化出重组体硫氰酸酶,其基本性质也得到阐述.     

哈氏弧菌谷胱甘肽还原酶基因克隆及原核表达

经克隆哈氏弧菌谷胱甘肽还原酶(GR)基因,并构建其原核表达载体,以获得相应的表达蛋白。将GR和p ET-32a(+)通过Bam H I和Xho I双酶切后,体外用T4连接酶连接,构建重组质粒p ET-GR;然后转化至大肠杆菌BL21(DE3)中,利用异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达,应用SDS-PAGE分析表达情况和表达条件。SDS-PAGE电泳获得分子量约为68.9 k D融合蛋白条带。在E.coli BL21(DE3)中重组质粒p ET-GR的表达条件为28℃,0.7 mmol/L的IPTG浓度诱导4 h表达量最高,且主要以包涵体形式表达。哈氏弧菌谷胱甘肽还原酶基因在大肠杆菌中获得了高效表达。     

Bacillaene酮还原酶结构域的异源表达及底物特异性分析

Bacillaene生物合成过程中,聚酮合酶第一个延伸模块的酮还原酶结构域(Bac KR1)既催化α酮基的还原,也催化β酮基的还原,具有天然的底物宽泛性。为进一步研究该结构域的底物特异性,在大肠杆菌中对其进行了异源表达。体外酶学分析表明Bac KR1可以催化聚酮类底物(±)-2-甲基-3-氧代戊酸-乙酰半胱胺硫酯外消旋体的立体选择性还原,仅生成4种非对映异构体中的一种,此外Bac KR1还可以催化环己酮和对氯苯乙酮等非聚酮类底物的还原,暗示了聚酮合酶中酮还原酶结构域作为生物催化剂的潜力。     

重组大肠杆菌表达氧化还原酶不对称还原2-羟基苯乙酮的研究

将来源于7种微生物的13个氧化还原酶基因分别与表达载体pET21c连接后,转化入Escherichia coli BL21(DE3)中,得到13株重组菌.重组菌在IPTG诱导下进行表达,并对2-羟基苯乙酮进行不对称催化还原.研究发现,在17℃下诱导表达的重组酶比活明显高于30℃和37℃下诱导表达的比活.另外,来源于Ca...     

嗜酸氧化亚铁硫杆菌启动子探针载体的构建

目的：为了研究嗜酸氧化亚铁硫杆菌（Acidithiobacillus ferrooxidans）启动子结构与功能。方法：以pSV-β-galactosidase质粒为骨架,通过定点突变的方法引入一个新的BstBⅠ单酶切位点,构建能在大肠杆菌（Escherichia coli）中正常复制的启动子探针载体。利用PCR的方法将A.ferrooxidans菌cycA2基因上游5＇段上游DNA片段克隆到探针载体β-半乳糖苷酶基因上游以替代其原有启动子（gpt启动子）,并将重组的质粒转化E.coliDH5α菌株。通过检测宿主细胞的β-半乳糖苷酶活性,来鉴定启动子片段,并分析了启动子探针质粒载体的功能及启动子的强度。结果：pSV-β-galactosidase质粒被正确突变,成功构建了启动子探针载体pSVB。来源于A. ferrooxidans菌的启动子片段可驱动β-半乳糖苷酶基因在E.coli细胞中表达,转化子酶活性约为gpt 启动子驱动下活性的70 %。结论：启动子探针载体（pSVB）可用于A. ferrooxidans菌或者其它原核生物启动子的分离及进一步的分析研究。酶活性分析结果表明,来源于A. ferrooxidans菌cycA2基因上游5＇段上游DNA片段具有显著启动子活性。     

嗜酸喜温硫杆菌硫加氧还原酶基因的克隆、表达及酶活性研究

旨为研究嗜酸喜温硫杆菌硫加氧还原酶的生化特性,以嗜酸喜温硫杆菌TST3的基因组DNA为模板,PCR扩增出硫加氧还原酶基因(sor),构建了表达载体p ET-sor,转化到Escherichia coli BL21(DE3)后,获得了重组菌株E.coli BL21(p ET-sor2)。SDS-PAGE实验证明,经IPTG诱导,该重组菌可以表达目的蛋白SOR。对诱导条件进行优化,并在最优的条件下诱导SOR酶表达,再经超声波破碎重组菌,上清液通过Ni+-NTA亲和层析柱纯化获得重组酶,其催化氧化反应的比酶活、Km值和Vmax分别为0.70U/mg,15.672×10-2 g/m L和12.755×10-5 mol/(L·min),而催化的还原反应的比酶活、Km值和Vmax分别为2.21 U/mg,0.507×10-2g/m L和4.876×10-5 mol/(L·min)。     

应用合成生物学策略构建全细胞生物催化剂合成(S)-乙偶姻

目的:在大肠杆菌宿主中过量表达丁二酮还原酶(DAR),同时构建辅酶NADH原位再生系统,利用全细胞高效催化丁二酮不对称还原合成(S)-乙偶姻。方法:PCR克隆多黏芽孢杆菌(Paenibacillus polymyxa) dar基因连到质粒pETDuet-1,转化至大肠杆菌(Escherichia coli) BL21(DE3),构建重组菌E. coli BL21(DE3)-DAR;通过Hi Trap TALON柱亲和层析纯化表达产物DAR酶蛋白,测定DAR的比酶活和分子动力学参数。在重组菌E. coli BL21(DE3)-DAR中构建辅酶NADH原位再生系统,协同表达枯草芽孢杆菌(Bacillus subtilis)的葡萄糖脱氢酶(GDH),构建重组菌E. coli BL21(DE3)-DAR/GDH,并以此重组菌为全细胞生物催化剂,优化催化条件,提高(S)-乙偶姻的产量和产率。结果:获得重组工程菌E. coli BL21(DE3)-DAR和E. coli BL21(DE3)-DAR/GDH。DAR以NADH为辅酶还原丁二酮的米氏常数Km、最大催化速率Vmax、催化常数Kcat分别为2. 59mmol/L、1. 64μmol/(L·min·mg)、12. 3/s,还原丁二酮生成(S)-乙偶姻光学的纯度为95. 86%,具有较好的催化效率和立体异构体选择性。构建辅酶NADH原位再生系统后,重组菌E. coli BL21(DE3)-DAR/GDH可高效催化丁二酮合成乙偶姻。在最优催化条件下分批补料,乙偶姻产量达51. 26g/L,转化率为81. 37%,生产速率为5. 13g/(L·h)。结论:使用非手性化合物原料丁二酮生产高附加值的手性化合物(S)-乙偶姻,以重组菌为全细胞生物催化剂合成(S)-乙偶姻,不需额外添加昂贵的辅酶,具有较高的生产应用价值。     

淀粉液化芽孢杆菌β1-1,3-1,4-葡聚糖酶基因的克隆及表达

为了比较不同的表达系统对β-1,3-1,4-葡聚糖酶基因(bgl)的效果,本研究将高产β-1,3-1,4-葡聚糖酶的淀粉液化芽孢杆菌Bacillus amyloliquefaciens BS5582的bgl基因(GenBank Accession No.EU623974)克隆到3种不同的质粒载体中,即构建pEGX-4T-1-bgl、pET20b(+)-bgl和pET28a(+)-bgl重组质粒.比较了pEGX-4T-1-bgl,在不同Escherichia coli宿主中表达效果,以及pET20b(+)-bgl和pET28a(+)-bgl在E coli BL21(DE3)中的表达效果.结果表明,E. coli BL21(DE3)-pET28a(+)-bgl能够表达最高的重组β-1,3-1,4-葡聚糖酶酶活,其总酶活可达(322.0±8.8)U/mL,是出发菌在最适摇瓶发酵条件下产酶活的40.1%.对该重组菌的产酶条件进行了分析,结合IPTG和乳糖协同的诱导作用,在基础产酶培养基中产最高总酶活为(1883.3±45.8)U/mL,表明其具有良好的工业应用价值.     

氧化亚铁硫杆菌中铜代谢相关两个基因的差异

目的:氧化亚铁硫杆菌(Acidithiobocllius ferrooxidans)在微生物冶金中发挥着重要的作用,研究其铜代谢机理有着十分典型的意义.在A.ferrooxidans全基因组序列数据库中,4个基因被注释与铜代谢相关.其中两个基因,Afe0454和Afe1073目前为止未发现有实验报道.本文旨在研究Afe0454和Afe1073与铜代谢的相关性.方法:通过一系列的方法如实时定量PER、反转录PER、序列分析,将基因导入抗铜基因缺陷的大肠杆菌(Escherichia coli)菌株中等,研究了Afe0454和Afe1073.结果:与Afe0454相比,Afe1073的表达对铜压力更敏感;Afe1073作为一个转录子单独转录,而Afe0454与Afe0453一起转录;序列分析显示Afe1073表达一种典型的重金属离子泵P1b1型ATP酶,而Afe0454表达一种未知功能的跨膜蛋白;不像Afe0454,Afe1073能使P1b型ATP酶敲除的大肠杆菌菌株铜抗性提高.结论:单独转录的Afe1073比Afe0454在铜代谢中发挥的作用更加明显.     

Crystal structure, detonation performance, and thermal stability of a new polynitro cage compound: 2, 4, 6, 8, 10, 12, 13, 14, 15-nonanitro-2, 4, 6, 8, 10, 12, 13, 14, 15-nonaazaheptacyclo [5.5.1.13, 11. 15, 9] pentadecane

A new polynitro cage compound 2, 4, 6, 8, 10, 12, 13, 14, 15-nonanitro-2, 4, 6, 8, 10, 12, 13, 14, 15-nonaazaheptcyclo [5.5.1.1(3,11).1(5,9)] pentadecane (NNNAHP) was designed in the present work. Its molecular structure was optimized at the B3LYP/6-31 G(d,p) level of density functional theory (DFT) and crystal structure was predicted using the Compass and Dreiding force fields and refined by DFT GGA-RPBE method. The obtained crystal structure of NNNAHP belongs to the P-1 space group and the lattice parameters are a = 9.99 ?, b = 10.78 ?, c = 9.99 ?, α = 90.01°, β = 120.01°, γ = 90.00°, and Z = 2, respectively. Based on the optimized crystal structure, the band gap, density of state, thermodynamic properties, infrared spectrum, strain energy, detonation characteristics, and thermal stability were predicted. Calculation results show that NNNAHP has detonation properties close to those of CL-20 and is a high energy density compound with moderate stability.     

Distribution of N,P, K,Ca, Mg,S, Zn,Fe, Mn and Cu in groundnut

Summary Concentration of N, P, K, Ca, Mg and S in summer groundnut crop was higher than in kharif while Zn, Fe, Mn and Cu contents were higher in summer crop. Kernel's N, P and Zn; Leaflet's Ca and Mn; Stem's K and Fe; Root's S and Cu and Petiole's Mg contents were highest. Shell's N, P, K, Mg, S, Zn and Cu; Kernel's Ca, Fe and Mn contents were the least. N, P, K, S, Zn and Cu concentrations decreased linearly as the crop grew. Ca, Mg, Fe and Mn concentrations did not display any distinct pattern. Ca concentration was positively correlated with pod yield in both the seasons.     

Simultaneous measurement of the trace elements Al, As, B, Be, Cd, Co, Cu, Fe, Li, Mn, Mo, Ni, Rb, Se, Sr, and Zn in human serum and their reference ranges by ICP-MS

The goal of this article was to establish reference ranges of the concentration of trace elements in human serum and to compare these results with those reported by other authors. We describe the sample preparation and measurement conditions that allow the rapid, precise, and accurate determination of Al, As, B, Be, Cd, Co, Cu, Fe, Li, Mn, Mo, Ni, Rb, Se, Sr, and Zn in human serum samples (n=110) by inductively coupled plasma-mass spectrometry (ICP-MS). Accuracy and precision were determined by analyzing three reconstituted reference serum samples by comparison with other methods and by the standard addition procedure. The advantages of the ICP-MS method include short time of analysis of the elements mentioned, low detection limit, high precision, and high accuracy. Disadventages include a high risk of contamination due to the presence of some of the elements of interest in the environment, the relatively delicate sample handling, and the high cost of the equipment.     

Reference values for the concentrations of As,Cd, Co,Cr, Cu,Fe, I,Hg, Mn,Mo, Ni,Pb, Se,and Zn in selected human tissues and body fluids

This report attempts to formulate reference ranges of elemental concentrations for 15 trace elements in selected human tissues and body fluids. A set of samples consisting of whole blood, blood serum, urine, milk, liver, and hair were chosen and considered for 15 elements of biological significance: As, Cd, Co, Cr, Cu, F, Fe, I, Hg, Mn, Mo, Ni, Pb, Se, and Zn. The results represent wholly or partially data received from 40 countries of the global regions of Africa, Asia, Europe, North, South, and Central America, Australia, and New Zealand. This survey, even if qualitative, has been useful in demonstrating certain trends of trace-element scenarios around the world. It is of course recognized that both diet and environment exert a strong influence on the distribution pattern of several elements, such as As, Cd, Mn, Pb, Se, and Zn. A limited comparison of the available information on soil status of different countries reflected some interesting associations for elements, such as Mn and Zn. Importantly, this study revealed that only a few countries were in a position to identify a reasonable amount of data on samples requested for this project. Regretably, for a number of countries, any dependable data for even such essential elements as Cu, Fe, and Zn were not available. In view of the nutritional importance of many elements, the time is ripe for concerted efforts by intergovernmental agencies to initiate investigations or commission task forces/projects to generate reliable reference data for selected global regions, which sadly lack data of any kind at present.     

Relations of the Al,B, Ba,Br, Ca,Cl, Cu,Fe, K,Li, Mg,Mn, Na,P, S,Si, Sr,and Zn mass fractions to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands

The variation with age of the 18 trace element mass fractions and some histological characteristics of intact prostate glands of 50 subjects aged 0–30 years was investigated by instrumental neutron activation analysis, inductively coupled plasma atomic emission spectrometry, and a quantitative morphometric analysis. Mean values ± standard error of the mean (M ± SΕΜ) for the mass fractions (in milligrams per kilogram wet tissue) of these trace elements in pre-puberty were: Al 28.5 ± 9.0, B 0.40 ± 0.11, Ba 1.48 ± 0.44, Br 10.5 ± 1.5, Ca 241 ± 30, Cl 3,203 ± 278, Cu 3.51 ± 0.89, Fe 33.7 ± 4.1, K 2,364 ± 145, Li 0.020 ± 0.004, Mg 153 ± 23, Mn 0.46 ± 0.06, Na 2,286 ± 130, P 1,391 ± 100, S 1,698 ± 132, Si 62 ± 11, Sr 0.38 ± 0.08, and Zn 27.6 ± 2.3. During puberty and postpuberty, when there is a significant increase in circulating androgens, the mean values were: Al 7.2 ± 1.4, B 0.21 ± 0.05, Ba 0.25 ± 0.06, Br 5.8 ± 1.0, Ca 433 ± 81, Cl 2,314 ± 201, Cu 1.77 ± 0.13, Fe 20.9 ± 1.6, K 2,585 ± 118, Li 0.0088 ± 0.0014, Mg 232 ± 27, Mn 0.34 ± 0.04, Na 1,875 ± 107, P 1,403 ± 98, S 1,673 ± 73, Si 22.2 ± 3.1, Sr 0.22 ± 0.03, and Zn 93.3 ± 8.9. Mean values (M ± SΕΜ) of percent volumes (%) of the stroma, epithelium and lumen in the prostate before puberty were 73.4 ± 2.6, 20.4 ± 1.7, and 4.45 ± 0.94, respectively, versus 46.5 ± 2.5, 38.5 ± 1.9, and 14.9 ± 1.2 during puberty and postpuberty. This work’s results confirm that the Zn mass fraction in prostate tissue is an androgen-dependent parameter. For the first time it has been demonstrated that the glandular lumen is a main pool of Ca, Mg, and Zn accumulation and that the stroma is a main pool of Al, B, Ba, Br, Cl, Cu, Fe, Mn, Na, and Si accumulation in the normal human prostate, for the age range 0–30 years. It was concluded that the Ca, Mg, and Zn binds tightly within the prostatic fluid, because the volume of glandular lumen reflects the volume of prostatic fluid.     

The Effect of Age and Gender on Al, B, Ba, Ca, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Sr, V, and Zn Contents in Rib Bone of Healthy Humans

The effect of age and gender on major, minor, and trace element contents in the intact rib bone of 80 relatively healthy 15–55-year-old women and men was investigated. Contents or upper limit of contents of 16 chemical elements in the rib bone were determined by inductively coupled plasma atomic emission spectrometry (ICP-AES). Mean values (M?±?SΕΜ) for the mass fraction of Ba, Ca, Cu, Fe, K, Li, Mg, Na, P, S, Sr, and Zn (milligram per kilogram of dry bone) were as follows: 2.54?±?0.16, 171,400?±?4,050, 1.35?±?0.22, 140?±?11, 1,874?±?71, 0.049?±?0.011, 2,139?±?38, 5,378?±?88, 75,140?±?1,660, 1,881?±?51, 291?±?20, and 92.8?±?1.5, respectively. The upper limits of contents of Al, B, Mn, and V were <7.20, <0.65, <0.36, and <0.03, respectively. Statistically significant tendency for the Ca, Mg, and P content to decrease with age was found in the human rib bone, regardless of gender. The mass fraction of Fe in the male rib bone increases with age. It was shown that higher Ca, Mg, Na, P, and Sr mass fractions as well as lower Fe content were typical of female ribs as compared to those in male ribs.     

Potential Compounds for Oral Cancer Treatment: Resveratrol,Nimbolide, Lovastatin,Bortezomib, Vorinostat,Berberine, Pterostilbene,Deguelin, Andrographolide,and Colchicine

Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries. There are very limited treatment options available for oral cancer. Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities. We mined the large pool of compounds from the publicly available compound databases, to identify potential therapeutic compounds for oral cancer. Over 84 million compounds were screened for the possible anti-cancer activity by custom build SVM classifier. The molecular targets of the predicted anti-cancer compounds were mined from reliable sources like experimental bioassays studies associated with the compound, and from protein-compound interaction databases. Therapeutic compounds from DrugBank, and a list of natural anti-cancer compounds derived from literature mining of published studies, were used for building partial least squares regression model. The regression model thus built, was used for the estimation of oral cancer specific weights based on the molecular targets. These weights were used to compute scores for screening the predicted anti-cancer compounds for their potential to treat oral cancer. The list of potential compounds was annotated with corresponding physicochemical properties, cancer specific bioactivity evidences, and literature evidences. In all, 288 compounds with the potential to treat oral cancer were identified in the current study. The majority of the compounds in this list are natural products, which are well-tolerated and have minimal side-effects compared to the synthetic counterparts. Some of the potential therapeutic compounds identified in the current study are resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine.